首页> 美国卫生研究院文献>Intractable Rare Diseases Research >An update on microRNAs as potential novel therapeutic targets in testicular germ cell tumors
【2h】

An update on microRNAs as potential novel therapeutic targets in testicular germ cell tumors

机译:MicroRNA的更新作为睾丸生殖细胞肿瘤中的潜在新型治疗靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Testicular germ cell tumors (TGCTs) are the most frequent solid malignant tumors in men 20- 40 years of age and the most frequent cause of death from solid tumors in this age group. Recent studies have underscored the fact that miRNA deregulation is a feature of carcinogenesis, including TGCT development and progression. MiRNAs are a group of small noncoding RNAs that bind to the 3′-untranslated region (UTR) of the targeted mRNAs, thus causing mRNA degradation or the inhibition of its translation, regulating gene expression in a temporal and tissue-specific manner. However, few miRNAs have been found to play key roles in TGCTs; recently, other miRNAs have been identified, representing novel potential therapeutic targets.
机译:睾丸生殖细胞肿瘤(TGCT)是男性中最常见的常态恶性肿瘤20 - 40岁,在该年龄组中的固体瘤中最常见的死亡原因。最近的研究强调了MiRNA Dereculation是致癌物的一种特征,包括TGCT开发和进展。 miRNA是一组小的非分量RNA,其与靶向mRNA的3'非翻译区(UTR)结合,从而导致mRNA降解或抑制其翻译,以时间和组织特异性方式调节基因表达。但是,已经发现很少的miRNA在TGCT中发挥关键作用;最近,已经确定了其他miRNA,代表了新的潜在治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号